Suspected adverse drug reactions (ADRs) trends in older Italian patients: an analysis from the National Pharmacovigilance Network.

Gianluca Sferrazza Giuseppe Nicotera Pasquale Pierimarchi

Published in: Aging clinical and experimental research (2019)

These data suggest the need to optimize the clinical strategy for older patients due to the multiple factors that increase the susceptibility to ADRs. There is a high need to potentiate clinical trials on older patients to adopt new diagnostic-therapeutic pathways in real life.

Keyphrases

adverse drug
clinical trial
end stage renal disease
electronic health record
ejection fraction
newly diagnosed
chronic kidney disease
emergency department
peritoneal dialysis
randomized controlled trial
drug induced
quality improvement
big data
middle aged
open label
study protocol
deep learning